Franco Morelli

3.1k total citations
59 papers, 915 citations indexed

About

Franco Morelli is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Franco Morelli has authored 59 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 21 papers in Surgery. Recurrent topics in Franco Morelli's work include Renal cell carcinoma treatment (18 papers), Cancer Genomics and Diagnostics (12 papers) and Prostate Cancer Treatment and Research (9 papers). Franco Morelli is often cited by papers focused on Renal cell carcinoma treatment (18 papers), Cancer Genomics and Diagnostics (12 papers) and Prostate Cancer Treatment and Research (9 papers). Franco Morelli collaborates with scholars based in Italy, United States and Switzerland. Franco Morelli's co-authors include Evaristo Maiello, Lucia Lombardi, Saverio Cinieri, Laura Orlando, Ugo De Giorgi, Alessandra Bearz, Salvatore Siena, Daniele Santini, Orlando Todarello and Tiziana Pia Latiano and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Medicine.

In The Last Decade

Franco Morelli

57 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franco Morelli Italy 15 428 293 283 256 180 59 915
Tao Xu China 18 179 0.4× 230 0.8× 250 0.9× 357 1.4× 202 1.1× 104 1.0k
Mark Farrugia United States 15 277 0.6× 161 0.5× 172 0.6× 234 0.9× 119 0.7× 69 745
Moon‐Sing Lee Taiwan 19 243 0.6× 223 0.8× 225 0.8× 213 0.8× 122 0.7× 65 961
Jiang Li China 20 167 0.4× 319 1.1× 486 1.7× 421 1.6× 168 0.9× 83 1.2k
Ramazan Yıldız Türkiye 17 185 0.4× 176 0.6× 324 1.1× 163 0.6× 114 0.6× 115 868
Dimosthenis Chrysikos Greece 18 254 0.6× 311 1.1× 457 1.6× 253 1.0× 195 1.1× 119 1.2k
Mary Lou Affronti United States 17 325 0.8× 117 0.4× 318 1.1× 160 0.6× 181 1.0× 58 1.1k
Kimberley S. Mak United States 16 271 0.6× 315 1.1× 252 0.9× 119 0.5× 111 0.6× 50 948
Rangesh Kunnavakkam United States 17 420 1.0× 209 0.7× 249 0.9× 163 0.6× 160 0.9× 29 800
Martina Imbimbo Italy 19 515 1.2× 167 0.6× 796 2.8× 240 0.9× 133 0.7× 56 1.3k

Countries citing papers authored by Franco Morelli

Since Specialization
Citations

This map shows the geographic impact of Franco Morelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Morelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Morelli more than expected).

Fields of papers citing papers by Franco Morelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco Morelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Morelli. The network helps show where Franco Morelli may publish in the future.

Co-authorship network of co-authors of Franco Morelli

This figure shows the co-authorship network connecting the top 25 collaborators of Franco Morelli. A scholar is included among the top collaborators of Franco Morelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franco Morelli. Franco Morelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mennitto, Alessia, Elena Verzoni, Francesco Cognetti, et al.. (2021). Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial. Expert Review of Clinical Pharmacology. 14(2). 261–268. 7 indexed citations
2.
Calvani, Nicola, Franco Morelli, Emanuele Naglieri, et al.. (2019). Metronomic chemotherapy with cyclophosphamide plus low dose of corticosteroids in advanced castration-resistant prostate cancer across the era of taxanes and new hormonal drugs. Medical Oncology. 36(9). 80–80. 14 indexed citations
3.
Sbrana, Andrea, Elisa Biasco, Claudia Caserta, et al.. (2018). Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience. Anticancer Research. 38(8). 4913–4918. 3 indexed citations
4.
Re, Marzia Del, Tiziana Pia Latiano, Giuliana Restante, et al.. (2017). Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment. The EPMA Journal. 8(1). 69–73. 5 indexed citations
5.
Bosso, Davide, Martina Pagliuca, Guru Sonpavde, et al.. (2017). PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide. Medicine. 96(24). e6817–e6817. 6 indexed citations
6.
Lorenzo, Giuseppe Di, Guru Sonpavde, Gregory R. Pond, et al.. (2017). Statin Use and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Abiraterone Acetate. European Urology Focus. 4(6). 874–879. 22 indexed citations
7.
Passalacqua, Rodolfo, Silvia Lazzarelli, Maddalena Donini, et al.. (2017). Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01–2014). BMC Cancer. 17(1). 493–493. 4 indexed citations
8.
Lucarelli, Giuseppe, Monica Rutigliano, Matteo Ferro, et al.. (2017). Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 35(7). 461.e15–461.e27. 108 indexed citations
9.
Buti, Sebastiano, Melissa Bersanelli, Francesca Maines, et al.. (2016). First-Line PAzopanib in NOn–clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study. Clinical Genitourinary Cancer. 15(4). e609–e614. 39 indexed citations
10.
Houédé, Nadine, Gottfried J. Locker, Héctor Soto Parrà, et al.. (2016). Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy. BMC Cancer. 16(1). 752–752. 5 indexed citations
11.
Basso, Umberto, Marco Maruzzo, Franco Morelli, et al.. (2015). Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey. Clinical Genitourinary Cancer. 14(2). e161–e169. 12 indexed citations
12.
Calvani, Nicola, Franco Morelli, Vincenzo Emanuele Chiurì, et al.. (2013). Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike?. Medical Oncology. 30(2). 578–578. 8 indexed citations
13.
Calvani, Nicola, Franco Morelli, Silvana Leo, et al.. (2011). Sequential use of sorafenib and sunitinib in advanced renal cell carcinoma: does the order of sequencing matter?. Medical Oncology. 29(3). 1908–1913. 12 indexed citations
14.
Lombardi, Lucia, Franco Morelli, Saverio Cinieri, et al.. (2010). Adjuvant colon cancer chemotherapy: where we are and where we'll go. Cancer Treatment Reviews. 36. S34–S41. 72 indexed citations
15.
Morelli, Franco, et al.. (2010). Alexithymia and Cancer Pain: The Effect of Psychological Intervention. Psychotherapy and Psychosomatics. 79(3). 156–163. 49 indexed citations
16.
Manzini, Vincenzo de Pangher, Mara A. Cafferata, Camillo Porta, et al.. (2009). Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Annals of Oncology. 21(2). 348–353. 73 indexed citations
17.
Feliciani, Claudio, et al.. (2000). A case of imported tungiasis.. Redia-Giornale Di Zoologia. 135(6). 727–729. 1 indexed citations
18.
Valbonesi, M., Renato Bruni, G. Lercari, et al.. (1999). Autoapheresis and intraoperative blood salvage in oncologic surgery. Transfusion Science. 21(2). 129–139. 21 indexed citations
19.
Tradati, N, Luca Calabrese, L. Costa, et al.. (1997). Oral leukoplakias: to treat or not?. Oral Oncology. 33(5). 317–321. 39 indexed citations
20.
Gambardella, Antonio, Umberto Aguglia, Renzo Guerrini, et al.. (1996). Sequential occurrence of benign partial epilepsy and childhood absence epilepsy in three patients. Brain and Development. 18(3). 212–215. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tao Xu Breakdown of academic impact, for papers by Mark Farrugia Breakdown of academic impact, for papers by Moon‐Sing Lee Breakdown of academic impact, for papers by Jiang Li Breakdown of academic impact, for papers by Ramazan Yıldız Breakdown of academic impact, for papers by Dimosthenis Chrysikos Breakdown of academic impact, for papers by Mary Lou Affronti Breakdown of academic impact, for papers by Kimberley S. Mak Breakdown of academic impact, for papers by Rangesh Kunnavakkam Breakdown of academic impact, for papers by Martina Imbimbo
Rankless by CCL
2026